Healthcare
Monday, June 20, 2016
BRIEF-Theravance Biopharma highlights positive results from phase 3 fulfil study of closed triple announced by Glaxosmithkline, Innoviva
* Highlights positive top-line results from pivotal phase 3
fulfil study of closed triple announced by Glaxosmithkline,
Innoviva
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment